ES2131152T3 - Procedimiento para aislar selectivamente beta-2'-desoxi-2',2'-difluorocitidina o sus sales. - Google Patents

Procedimiento para aislar selectivamente beta-2'-desoxi-2',2'-difluorocitidina o sus sales.

Info

Publication number
ES2131152T3
ES2131152T3 ES94202041T ES94202041T ES2131152T3 ES 2131152 T3 ES2131152 T3 ES 2131152T3 ES 94202041 T ES94202041 T ES 94202041T ES 94202041 T ES94202041 T ES 94202041T ES 2131152 T3 ES2131152 T3 ES 2131152T3
Authority
ES
Spain
Prior art keywords
difluorocitidine
desoxi
salts
procedure
selectively isolating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94202041T
Other languages
English (en)
Inventor
Ta-Sen Chou
Perry Clark Heath
Lawrence Edward Patterson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2131152T3 publication Critical patent/ES2131152T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Epoxy Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA UN PROCESO PARA PREPARAR INTERMEDIOS DE LACTONA A 2'',2''-DIFLUORONUCLEOSIDOS POR LO QUE SE MINIMINIZA LA CONVERSION AL PRECURSOR DE LA CADENA ABIERTA DE LACTONA Y EL ENANTIOMERO ERITRO DESEADO PUEDE SER AISLADO SELECTIVMAENTE DESDE UNA MEZCLA DE ENANTIOMERO DE ERITOTREO Y LACTONAS EN FORMA CRISTALINA. TAMBIEN SE PROPORCIONA UN PROCESO PARA PRODUCIR 2''-DEOXI2'',2''-DIFLUORONUCLEOSIDOS EN UNA PROPORCION ANOMERICA APROXIMADA DE 1:1 (ALFA)/(BETA), Y PROCESOS PARA AISLAR SELECTIVAMENTE (BETA)-2''-DEOXI-2'',2''DIFLUOROCITIDINA, O UN ACIDO ORGANICO O INORGANICO EN ADICION DE UNA SAL DEL MISMO, PROCEDENTE DE LA MEZCLA 1:1 (ALFA)/(BETA).
ES94202041T 1987-08-28 1988-08-22 Procedimiento para aislar selectivamente beta-2'-desoxi-2',2'-difluorocitidina o sus sales. Expired - Lifetime ES2131152T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9072587A 1987-08-28 1987-08-28

Publications (1)

Publication Number Publication Date
ES2131152T3 true ES2131152T3 (es) 1999-07-16

Family

ID=22224017

Family Applications (4)

Application Number Title Priority Date Filing Date
ES94202041T Expired - Lifetime ES2131152T3 (es) 1987-08-28 1988-08-22 Procedimiento para aislar selectivamente beta-2'-desoxi-2',2'-difluorocitidina o sus sales.
ES88307750T Expired - Lifetime ES2113845T3 (es) 1987-08-28 1988-08-22 Procedimiento de preparacion de intermediarios utiles en la preparacion de 2',2'-difluoronucleosidos.
ES95201846T Expired - Lifetime ES2157289T3 (es) 1987-08-28 1988-08-22 Procedimiento para la preparacion de 2'-desoxi-2',2'-difluoronucleosidos.
ES95201845T Expired - Lifetime ES2176279T3 (es) 1987-08-28 1988-08-22 Procedimiento estereoselectivo para preparar 2`-2`-difluorolactonen protegidos.

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES88307750T Expired - Lifetime ES2113845T3 (es) 1987-08-28 1988-08-22 Procedimiento de preparacion de intermediarios utiles en la preparacion de 2',2'-difluoronucleosidos.
ES95201846T Expired - Lifetime ES2157289T3 (es) 1987-08-28 1988-08-22 Procedimiento para la preparacion de 2'-desoxi-2',2'-difluoronucleosidos.
ES95201845T Expired - Lifetime ES2176279T3 (es) 1987-08-28 1988-08-22 Procedimiento estereoselectivo para preparar 2`-2`-difluorolactonen protegidos.

Country Status (11)

Country Link
EP (4) EP0688783B1 (es)
JP (5) JP2738540B2 (es)
KR (1) KR970002659B1 (es)
AT (4) ATE164847T1 (es)
CA (1) CA1324128C (es)
DE (4) DE3856527T2 (es)
ES (4) ES2131152T3 (es)
GR (1) GR3026611T3 (es)
HU (3) HU206886B (es)
IE (1) IE81131B1 (es)
IL (1) IL87517A (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2012129A1 (en) * 1989-03-20 1990-09-20 Ramakrishnan Nagarajan Recovery of difluoro sugar
US5256798A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів
US5256797A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for separating 2-deoxy-2,2-difluoro-D-ribofuranosyl alkylsulfonate anomers
US5401861A (en) * 1992-06-22 1995-03-28 Eli Lilly And Company Low temperature process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
US5252756A (en) * 1992-06-22 1993-10-12 Eli Lilly And Company Process for preparing beta-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl-arylsulfonates
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
US5559222A (en) * 1995-02-03 1996-09-24 Eli Lilly And Company Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose
CA2239891A1 (en) 1995-12-13 1997-06-19 John Ashley Weigel .alpha., .alpha.-difluoro-.beta.-hydroxy thiol esters and their synthesis
KR100578616B1 (ko) * 2004-07-23 2006-05-10 한미약품 주식회사 Ｄ-에리트로-2,2-다이플루오로-2-데옥시-1-옥소라이보스화합물의 제조방법
JP2009513623A (ja) 2005-10-28 2009-04-02 アーチ ファーマラブズ リミテッド 塩酸ジェムシタビンの改良された製造方法
WO2007069838A1 (en) * 2005-12-14 2007-06-21 Dong-A Pharm.Co., Ltd. A manufacturing process of 2',2'-difluoronucleoside and intermediate
KR100741310B1 (ko) * 2006-08-01 2007-08-01 (주) 유일팜테크 젬시타빈의 합성에 유용한 신규한나프탈렌-2-카르복실레이트 유도체와 그의 제조방법
JP5349342B2 (ja) * 2007-03-23 2013-11-20 ドンウ シンテック カンパニー リミテッド ２’−デオキシ−２’，２’−ジフルオロシチジンの製造方法
JP2011524369A (ja) * 2008-06-12 2011-09-01 サイノファーム タイワン リミテッド ゲムシタビン塩基の結晶多形
GB0812895D0 (en) 2008-07-15 2008-08-20 Glycom As Crystalline carbohydrate derivative

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
ATE92499T1 (de) * 1984-12-04 1993-08-15 Lilly Co Eli Tumorbehandlung bei saeugetieren.
CA1295998C (en) * 1985-07-29 1992-02-18 Sai P. Sunkara Nucleosides and their use as antineoplastic agents

Also Published As

Publication number Publication date
EP0688782B1 (en) 2002-05-02
ES2157289T3 (es) 2001-08-16
EP0688782A1 (en) 1995-12-27
JP2899577B2 (ja) 1999-06-02
GR3026611T3 (en) 1998-07-31
DE3856477D1 (de) 2001-07-19
ATE164847T1 (de) 1998-04-15
IE81131B1 (en) 2000-03-22
HU906268D0 (en) 1991-03-28
JP2738540B2 (ja) 1998-04-08
HU206886B (en) 1993-01-28
IL87517A (en) 1993-05-13
DE3856330D1 (de) 1999-06-10
EP0688783B1 (en) 2001-06-13
IL87517A0 (en) 1989-01-31
EP0306190A3 (en) 1991-11-21
KR970002659B1 (ko) 1997-03-07
EP0630905A1 (en) 1994-12-28
JP2810034B2 (ja) 1998-10-15
KR890003794A (ko) 1989-04-18
JPH1072483A (ja) 1998-03-17
EP0306190A2 (en) 1989-03-08
HU9201768D0 (en) 1992-08-28
IE882608L (en) 1989-02-28
DE3856158T2 (de) 1998-08-20
EP0688783A1 (en) 1995-12-27
EP0306190B1 (en) 1998-04-08
ES2176279T3 (es) 2002-12-01
DE3856477T2 (de) 2001-11-08
DE3856527T2 (de) 2002-10-31
JPS6471894A (en) 1989-03-16
JP2777359B2 (ja) 1998-07-16
EP0630905B1 (en) 1999-05-06
CA1324128C (en) 1993-11-09
HU202249B (en) 1991-02-28
DE3856158D1 (de) 1998-05-14
JPH1081696A (ja) 1998-03-31
HUT47590A (en) 1989-03-28
ATE202113T1 (de) 2001-06-15
ES2113845T3 (es) 1998-05-16
DE3856330T2 (de) 1999-09-30
JP2899576B2 (ja) 1999-06-02
ATE179713T1 (de) 1999-05-15
JPH1072484A (ja) 1998-03-17
JPH1072457A (ja) 1998-03-17
DE3856527D1 (de) 2002-06-06
ATE217009T1 (de) 2002-05-15

Similar Documents

Publication Publication Date Title
ES2131152T3 (es) Procedimiento para aislar selectivamente beta-2'-desoxi-2',2'-difluorocitidina o sus sales.
ES8706165A1 (es) Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida.
MY102581A (en) Process for production of avermectins and cultures therefor
ES2038310T3 (es) Procedimiento para la sintesis de derivados de 3-tio-4-quinolona y sus compuestos intermedios.
DE3586017D1 (de) Stabiles glukose-isomerase-konzentrat und verfahren zu dessen herstellung.
PT89249A (pt) Processo para a preparacao de novos derivados de piperidinilo 1,4-dissubstituido com actividade terapeutica
DE3784988D1 (de) Methode fuer selektiven zuwachs des anteils der gewoenlichen hauptkomponente des antibiotischen komplexes a/16686.
FI884250L (fi) Menetelmä suurien levymäisten, neulamaisten kipsikiteiden valmistamiseksi
DE3767993D1 (de) Verfahren zur herstellung von thienylaethylaminen, und mittels des verfahrens hergestellte dithienylaethylamine.
BR8807606A (pt) Processo para producao de magnesio por reducao metalotermica
IT1261230B (it) Procedimento migliorato per la preparazione di l-(-)-carnitina a partire da suoi precursori aventi opposta configurazione.
DE3785266D1 (de) Stamm zur massenproduktion von epsilon-poly-l-lysin, methode, um diesen stamm zu gebrauchen, und methode zur herstellung von epsilon-poly-l-lysin.
ATE36318T1 (de) Verfahren zur herstellung von azetidinderivaten und zwischenprodukte.
ATE34176T1 (de) 2'-chloropentostatin, eine diese verbindung enthaltende pharmazeutische zusammensetzung und ein mikroorganismus zur herstellung dieser verbindung.
PT87931A (pt) Processo para a preparacao de derivados da antraciclina com accao citostatica
UA3421C1 (uk) Спосіб одержання похідних 2-тіазолідінону
BR8607101A (pt) Processo para a producao de cloro-tolonila
SU1593572A3 (ru) Cпocoб пoлучehия tиoфehobыx coeдиhehий или иx opгahичeckиx coлeй
ATE107631T1 (de) Verfahren zur herstellung von indolinon-2- derivaten.
FI883316A7 (fi) 3-asyylioksibisyklo/3.3.0/oktan-7-oni-2-karboksyylihappoesterirasemaattien hajotus stereospesifisellä, entsymaattisella tai mikrobiologisella asylaatin hydrolyysillä
PT80351A (en) Process for preparing fenoldopam 4',8-bis-hydrogen sulfates
ES2051839T3 (es) Un procedimiento para preparar tiadiazol-guanidinas.
YU43881B (en) Process for obtaining crystalline salt of s-6-fluor-4-(benzyloxi-carbonylamino )chroman-4-carbonic acid
ATE118551T1 (de) Verfahren zur herstellung von s-2,2-r1,r2-1,3- dioxolan-4-methanol.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 630905

Country of ref document: ES